Journal article
Coating Nanoparticles with Plant-Produced Transferrin–Hydrophobin Fusion Protein Enhances Their Uptake in Cancer Cells
FI-02044 Espoo1
Division of Pharmaceutical Chemistry and Technology, Drug Research Program, Faculty of Pharmacy2
Department of Micro- and Nanotechnology3
Laboratory of Industrial Physics, Department of Physics and Astronomy4
London Research and Development Centre5
Helsinki Institute of Life Science (HiLIFE)6
The encapsulation of drugs to nanoparticles may offer a solution for targeted delivery. Here, we set out to engineer a self-assembling targeting ligand by combining the functional properties of human transferrin and fungal hydrophobins in a single fusion protein. We showed that human transferrin can be expressed in Nicotiana benthamiana plants as a fusion with Trichoderma reesei hydrophobins HFBI, HFBII, or HFBIV.
Transferrin–HFBIV was further expressed in tobacco BY-2 suspension cells. Both partners of the fusion protein retained their functionality; the hydrophobin moiety enabled migration to a surfactant phase in an aqueous two-phase system, and the transferrin moiety was able to reversibly bind iron. Coating porous silicon nanoparticles with the fusion protein resulted in uptake of the nanoparticles in human cancer cells.
This study provides a proof-of-concept for the functionalization of hydrophobin coatings with transferrin as a targeting ligand.
| Language: | English |
|---|---|
| Publisher: | American Chemical Society |
| Year: | 2017 |
| ISSN: | 15204812 and 10431802 |
| Types: | Journal article |
| DOI: | 10.1021/acs.bioconjchem.7b00075 |
